First Quadrant’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,500
Closed -$96K 585
2020
Q3
$96K Sell
2,500
-11,402
-82% -$439K 0.01% 434
2020
Q2
$488K Sell
13,902
-8,898
-39% -$320K 0.07% 265
2020
Q1
$744K Sell
22,800
-4,700
-17% -$184K 0.11% 204
2019
Q4
$1.24M Sell
27,500
-60,406
-69% -$2.53M 0.1% 196
2019
Q3
$3.58M Hold
87,906
0.34% 74
2019
Q2
$3.78M Buy
87,906
+49,113
+127% +$1.89M 0.26% 90
2019
Q1
$1.49M Sell
38,793
-19,090
-33% -$729K 0.11% 194
2018
Q4
$2.05M Sell
57,883
-670,487
-92% -$24.3M 0.16% 132
2018
Q3
$28M Sell
728,370
-291,380
-29% -$10.2M 0.62% 25
2018
Q2
$33.3M Buy
1,019,750
+974,454
+2,151% +$29.4M 0.62% 26
2018
Q1
$1.24M Buy
45,296
+2,696
+6% +$73.3K 0.02% 377
2017
Q4
$1.06M Hold
42,600
0.02% 429
2017
Q3
$1.24M Hold
42,600
0.02% 407
2017
Q2
$1.18M Hold
42,600
0.02% 407
2017
Q1
$1.06M Hold
42,600
0.02% 449
2016
Q4
$921K Hold
42,600
0.02% 449
2016
Q3
$1.01M Hold
42,600
0.02% 430
2016
Q2
$996K Buy
42,600
+14,100
+49% +$305K 0.02% 384
2016
Q1
$536K Buy
+28,500
New +$501K 0.01% 483
2013
Q4
Sell
-153,400
Closed -$1.8M 794
2013
Q3
$1.8M Buy
+153,400
New +$1.66M 0.05% 309

Other funds holding BSX

First Quadrant's BSX Position: Q4 2020 in Review

First Quadrant sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 2,500 shares — an estimated $96K sold.

First Quadrant first reported a position in BSX in Q3 2013 and held it in 20 quarters. The position peaked at $33.3M in Q2 2018. 864 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • First Quadrant reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • First Quadrant sold 2,500 Boston Scientific shares in Q4 2020, an estimated $96K.
  • First Quadrant first reported a position in Boston Scientific in Q3 2013 and held it in 20 quarters.
  • First Quadrant's Boston Scientific position peaked at $33.3M in Q2 2018.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on First Quadrant's 13F filing for Q4 2020, filed 27 Jan 2021.